Filtered By:
Drug: Fortamet
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 8614 results found since Jan 2013.
Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
CONCLUSION: Dapagliflozin, as an add-on or a switch therapy to lobeglitazone plus MFM, can be a suitable alternative for Korean patients with inadequately controlled T2DM. The combination therapy resulted in significant reductions in HbA1c levels, body weight, and blood pressure.PMID:36031782 | PMC:PMC9424781 | DOI:10.3349/ymj.2022.63.9.825
Source: Yonsei Medical Journal - August 29, 2022 Category: Universities & Medical Training Authors: Da Hea Seo Young Ju Suh Yongin Cho Seong Hee Ahn Seongha Seo Seongbin Hong Yong-Ho Lee Young Ju Choi Eunjig Lee So Hun Kim Source Type: research
< em > Jiangtang Sanhuang < /em > tablet inhibits endoplasmic reticulum stress and autophagy in diabetic mouse islet cells
CONCLUSION: JTSHT has protective effects against glycolipid toxicity in MIN6 cells possibly by inhibiting ERS and autophagy.PMID:36210704 | PMC:PMC9550554 | DOI:10.12122/j.issn.1673-4254.2022.09.07
Source: Journal of Southern Medical University - October 10, 2022 Category: Universities & Medical Training Authors: W Zhang Z Hu Source Type: research
